Mechanism for Resistance to Immunotherapy Treatment Discovered – Lab Manager Magazine
Lab Manager Magazine |
Mechanism for Resistance to Immunotherapy Treatment Discovered
Lab Manager Magazine An urgent question for cancer scientists is why immunotherapy achieves dramatic results in some cases but doesn’t help most patients. Now, two research groups from Dana-Farber Cancer Institute have independently discovered a genetic mechanism in cancer … |
ReliaWire |
Alcohol found to boost cancer risk by damaging stem cell DNA
BioNews Drinking alcohol damages blood stem cells by altering their DNA, raising the risk of developing cancer, scientists have found. A breakdown product of alcohol – acetaldehyde – is responsible for the damage, according to researchers at the MRC Laboratory … Here’s How Alcohol Can Damage DNA and Increase Cancer RiskLive Science How Alcohol Mutates Stem Cells And Damages ChromosomesReliaWire Alcohol Found To Physically Break DNA In Stem Cells, Providing Potential Cause For CancerInfosurhoy Theafricom –Sin Chew Jit Poh all 47 news articles » |
SMA News Today |
Gene–Therapy Update: Mixed Results Don’t Dim Hopes
Barron’s Three companies developing replacement gene–therapy treatments provided updates last week on clinical trials. Investors were happy with the news at Audentes Therapeutics (ticker: BOLD), and disappointed with what they heard from Avexis (AVXS) and … FDA Lets AveXis Know the Information It Needs to Approve AVXS-101 for SMA Type 1SMA News Today REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the …GlobeNewswire (press release) |
SMA News Today |
Gene–Therapy Update: Mixed Results Don’t Dim Hopes
Barron’s Three companies developing replacement gene–therapy treatments provided updates last week on clinical trials. Investors were happy with the news at Audentes Therapeutics (ticker: BOLD), and disappointed with what they heard from Avexis (AVXS) and … FDA Lets AveXis Know the Information It Needs to Approve AVXS-101 for SMA Type 1SMA News Today |
Wall Street Journal |
Stem Cells for Knee Problems? US Doctors Investigate
Wall Street Journal Jason Dragoo’s Stanford University research team gets 100 to 200 inquiries every day from people interested in joining its clinical trial studying the use of stem cells to treat knee injuries. The interest highlights a growing demand for the use of … |